Surgery Partners Corp (SGRY) - Market Cap to Earnings

Surgery Partners Group - graphic logo of issuer SGRY

The increasing number of procedures in outpatient centers is actively driving revenue growth for Surgery Partners, Inc. (SGRY). However, personnel expenses and insurance reimbursement rates are putting pressure on margins. Diversification into ophthalmology and orthopedics minimizes risks. The company's earnings multiple reflects the business value dynamics, where -39.50 sets the current value of the indicator, determining the balance between market price and actual income.

Surgery Partners Group - SGRY Price to Earnings Ratio (period 07/04/2022 - 11/12/2026)

Analytical breakdowns for Surgery Partners Corp (SGRY)

- stock value and consensus price forecast:
Comprehensive company analysis:surgerypartners.com - SGRY
Manufactured product of Surgery Partners Corp

The resilience of Surgery Partners, Inc. (SGRY) to market shocks is driven by inelastic demand for specialized center services and strong bargaining power with insurance companies. The ratio of market capitalization to net income, which reflects the investment payback period, allows for the determination of a fair valuation range for the asset through the company's P/E volatility to avoid overpaying during peaks of inflated expectations.

Key competitors

Price to Earnings Ratio HCA Holdings (HCA)|P/E Multiple THC|FMS - Market Cap to Earnings|Price to Earnings Ratio Solventum Inc. SOLV|EHC: Price to Earnings Multiple|UHS: Price to Earnings Ratio|davita.com - Market Price to Net Income Ratio|RadNet (RDNT) - Price to Earnings Ratio|OPCH - Business Payback Period|Price to Earnings Ratio PINC|P/E Multiple America's Best Contacts & Eyeglasses|Price to Earnings Ratio Progyny, Inc. (PGNY)|ARDT (ardenthealth.com) - Company Value to Net Income|P/E Multiple SEM (Select Medical Holdings)|Market Cap to Net Income Ratio Astrana Health Inc|Pediatrix Corp - P/E Multiple|Market Cap to Earnings U.S. Physical Therapy|The Pennant Group, Inc. (PNTG) - Price to Earnings Ratio|organogenesis.com - Company Value to Net Income|Price to Earnings Ratio NUTX|Market Cap to Earnings Auna S.A. AUNA|Price to Earnings Ratio SBC (SBC Medical Corp)|EOLS (Evolus Corp) - Company Value to Net Income|Price to Earnings Ratio Community Health Systems CYH|SKIN (The Beauty Health Company) - Market Cap to Net Income|MediWound, Ltd. - P/E Multiple|BTMD - P/E Multiple|The Joint Corporation (JYNT) - Price to Earnings Ratio|DocGo, Inc - Company Value to Net Income|Price to Earnings Ratio PIII|GANX (gaintherapeutics.com) - Market Price to Net Income Ratio|Price to Earnings Ratio EUDA Health Holdings Limited (EUDA)|baselmedical.com - Price to Earnings Multiple|P/E Multiple CLGN (CollPlant Biotechnologies Ltd.)|Cuprina Holdings Limited (CUPR) - Market Cap to Earnings|CCM - Price to Earnings Ratio|Company Value to Net Income AMS (ashs.com)|MEDIROM Healthcare Group (MRM) - Price to Earnings Ratio|ALBT - Business Payback Period|Price to Earnings Ratio DHAI|XAGE: Company Value to Net Income|P/E Multiple NIVF|Business Payback Period atipt.com|Price to Earnings Ratio CareMax CMAX|KDLY: Price to Earnings Multiple|LogistiCare - P/E Multiple|Novo Integrated Sciences Corp (NVOS) - Price to Earnings Ratio|SSY (sunlinkhealth.com) - Price to Earnings Ratio|BACK - Business Payback Period